Itoh Yoshifumi, Seiki Motoharu
Kennedy Institute of Rheumatology Division, Imperial College London, Hammersmith, London, United Kingdom.
J Cell Physiol. 2006 Jan;206(1):1-8. doi: 10.1002/jcp.20431.
Cells are regulated by many different means, and there is more and more evidence emerging that changes in the microenvironment greatly affect cell function. MT1-MMP is a type I transmembrane proteinase which participates in pericellular proteolysis of extracellular matrix (ECM) macromolecules. The enzyme is cellular collagenase essential for skeletal development, cancer invasion, growth, and angiogenesis. MT1-MMP promotes cell invasion and motility by pericellular ECM degradation, shedding of CD44 and syndecan1, and by activating ERK. Thus MT1-MMP is one of the factors that influence the cellular microenvironment and thereby affect cell-signaling pathways and eventually alters cellular behavior. As a proteinase, MT1-MMP is regulated by inhibitors, but it also requires formation of a homo-oligomer complex, localization to migration front of the cells, and internalization to become a "functionally active" cell function modifier. Developing new means to inhibit "functional activity" of MT1-MMP may be a new direction to establish treatments for the diseases that MT1-MMP mediates such as cancer and rheumatoid arthritis.
细胞受到多种不同方式的调控,并且越来越多的证据表明,微环境的变化会极大地影响细胞功能。MT1-MMP是一种I型跨膜蛋白酶,参与细胞外基质(ECM)大分子的细胞周围蛋白水解过程。该酶是骨骼发育、癌症侵袭、生长和血管生成所必需的细胞胶原酶。MT1-MMP通过细胞周围ECM降解、CD44和syndecan1的脱落以及激活ERK来促进细胞侵袭和迁移。因此,MT1-MMP是影响细胞微环境、进而影响细胞信号通路并最终改变细胞行为的因素之一。作为一种蛋白酶,MT1-MMP受抑制剂调控,但它还需要形成同型寡聚体复合物、定位于细胞迁移前沿并内化才能成为“功能活跃”的细胞功能调节剂。开发抑制MT1-MMP“功能活性”的新方法可能是为MT1-MMP介导的疾病(如癌症和类风湿性关节炎)建立治疗方法的新方向。